Our Technology Platform

A proprietary engine for designing and developing next-generation multi-specific antibody therapeutics.

Platform Capabilities

Engineering Beyond Bispecifics

Our platform integrates advanced protein engineering, patented covalent stabilization chemistry, and deep immunology expertise to create trispecific therapeutics with superior properties.

Intellectual Property

Protected Innovation

Our covalent multi-specific antibody platform is protected by granted US Patent 12,134,661 B1, covering the core technology underlying our pipeline of trispecific therapeutics.

Granted US patent covering covalent multi-specific formats
Freedom to operate across oncology and autoimmune indications
Growing global patent portfolio

See Our Platform in Action

Explore how our technology translates into a differentiated clinical pipeline.

View pipeline